Mode
Text Size
Log in / Sign up
Dr. Julia Lee, PhD
Medical Reviewer

Dr. Julia Lee, PhD

Oncology, Genomics & Drug Development — Molecular targets, biomarker-stratified trials, accelerated-approval pathways.

Dr. Julia Lee is a freelance medical writer specializing in Oncology, Genomics & Drug Development, with over 10+ years of experience spanning academic research, translational science, and scientific communication. She holds a PhD in Cancer Biology from Stanford University School of Medicine, with additional training in molecular biology, genomics, and translational oncology. She also holds certification in Good Clinical Practice (ICH-GCP) and has completed advanced professional training in medical writing and regulatory communication.

Her research background includes work on tumor microenvironment biology and treatment-related toxicity, with a strong focus on biomarker-driven oncology and precision medicine approaches.

Julia supports biopharmaceutical organizations in developing scientific content for molecularly targeted therapies, biomarker-stratified clinical trials, and drug development programs, including accelerated approval pathways. Her work spans scientific publications, clinical communication materials, and translational research documentation.

Articles in this group — last 14 days

Meta-analysis of surgical resection for lung neuroendocrine tumors
Oncology Meta-analysis
Meta-analysis of surgical resection for lung neuroendocrine tumors Sparing Lung Tissue May Save Lives Without Hurting Survival Rates
This meta-analysis of six studies compared lobectomy to sub-lobar resection for lung neuroendocrine tumors. It found no significant differen…
New research shows taking less lung tissue during surgery for rare tumors gives patients the same long-term survival chance as taking more.
Systematic review and meta-analysis compares intravesical gemcitabine/docetaxel versus BCG for non-muscle-invasive bladder cancer
Oncology Meta-analysis
Systematic review and meta-analysis compares intravesical gemcitabine/docetaxel versus BCG for non-muscle-invasive bladder cancer Gemcitabine and docetaxel show similar recurrence-free survival to BCG for bladder cancer
This systematic review and meta-analysis evaluated intravesical gemcitabine and docetaxel compared with Bacillus Calmette-Guérin (BCG) in pa…
A meta-analysis of 1634 patients found gemcitabine and docetaxel offered recurrence-free survival rates comparable to BCG therapy for non-mu…
FDA Approves Enhertu (fam-trastuzumab deruxtecan-nxki) for Multiple HER2-Positive and HER2-Low Cancers
Oncology FDA Approval
FDA Approves Enhertu (fam-trastuzumab deruxtecan-nxki) for Multiple HER2-Positive and HER2-Low Cancers FDA approves Enhertu for several types of HER2 positive cancers.
FDA approved Enhertu for several indications including HER2-positive metastatic breast cancer, HER2-low and HER2-ultralow breast cancer, HER…
The FDA has approved Enhertu for multiple cancers, including breast, lung, stomach, and other solid tumors that have a specific protein call…
FDA Approves Revlimid (lenalidomide) for Multiple Myeloma and Other Indications
Oncology FDA Approval
FDA Approves Revlimid (lenalidomide) for Multiple Myeloma and Other Indications FDA approves Revlimid for several blood cancers and related conditions.
FDA approved Revlimid (lenalidomide) for multiple myeloma (in combination with dexamethasone and as maintenance after auto-HSCT), transfusio…
The FDA approved Revlimid (lenalidomide) for multiple myeloma, certain myelodysplastic syndromes, mantle cell lymphoma, and other lymphomas.…
FDA Approves Pomalyst (pomalidomide) for Multiple Myeloma and Kaposi Sarcoma
Oncology FDA Approval
FDA Approves Pomalyst (pomalidomide) for Multiple Myeloma and Kaposi Sarcoma FDA approves new drug Pomalyst for multiple myeloma and Kaposi sarcoma.
The FDA approved Pomalyst (pomalidomide) for multiple myeloma in combination with dexamethasone after at least two prior therapies, and for …
The FDA approved Pomalyst (pomalidomide) for two conditions: multiple myeloma and Kaposi sarcoma. It offers a new option for patients who ha…
Darolutamide plus ADT delays pain progression in metastatic hormone-sensitive prostate cancer
Oncology RCT
Darolutamide plus ADT delays pain progression in metastatic hormone-sensitive prostate cancer New treatment delays pain in advanced prostate cancer
This randomised, double-blind, phase 3 trial in men with metastatic hormone-sensitive prostate cancer found that darolutamide plus androgen …
Men with advanced prostate cancer who took darolutamide stayed pain-free longer and felt better overall for months compared to those on stan…
PSA levels at 6, 12, and 24 weeks post-randomization correlate with 96-month survival in prostate cancer
Oncology RCT
PSA levels at 6, 12, and 24 weeks post-randomization correlate with 96-month survival in prostate cancer Low PSA at 24 weeks predicts longer survival in prostate cancer
This post-hoc analysis of five phase 3 trials in 7129 patients with prostate cancer found that 96-month overall survival varied by metastati…
Men with prostate cancer who hit a PSA level of 0.2 ng/mL or less within 24 weeks of starting treatment are far more likely to survive at le…
MRgSBRT and replanned CTgSBRT show similar organ-at-risk dosimetry in prostate cancer
Drug Pipeline Phase III
MRgSBRT and replanned CTgSBRT show similar organ-at-risk dosimetry in prostate cancer Replanning CT scans with smaller margins improved safety for prostate cancer patients compared to standard plans
This post hoc analysis of a Phase 3 trial replanned CT-guided SBRT for localized prostate cancer. Reducing PTV margins to 3 mm or 2 mm produ…
Doctors re-planned radiation for prostate cancer using tighter margins. This change lowered the chance of rectal problems and kept bladder s…
Extended Risankizumab Benefits Initial Nonresponders in Ulcerative Colitis
Drug Pipeline RCT
Extended Risankizumab Benefits Initial Nonresponders in Ulcerative Colitis Over half of ulcerative colitis patients found relief with longer treatment
Over 50% of patients with ulcerative colitis who did not respond to initial risankizumab achieved clinical response with 12 more weeks of ex…
More than half of patients with ulcerative colitis who did not respond to initial treatment found clinical response with extended risankizum…
Segment 4b/5 resection versus wedge resection showed no impact on long-term oncological outcomes in gallbladder cancer patients
Drug Pipeline RCT
Segment 4b/5 resection versus wedge resection showed no impact on long-term oncological outcomes in gallbladder cancer patients Surgical removal of specific liver parts did not improve survival or safety for gallbladder cancer patients
This phase 3 randomized controlled trial enrolled 163 patients undergoing surgery for gallbladder cancer after ruling out metastatic or unre…
Doctors compared two ways to remove part of the liver during gallbladder cancer surgery. Patients who had the larger cut stayed in the hospi…
Acoltremon 0.003% twice daily increased tear production in adults with Dry Eye Disease
Drug Pipeline RCT
Acoltremon 0.003% twice daily increased tear production in adults with Dry Eye Disease New dry eye treatment boosts tear production in adults over 30
In two randomized, multicenter, double-masked phase 3 trials in adults with Dry Eye Disease, acoltremon 0.003% twice daily significantly inc…
A new dry eye treatment boosted tear production and reduced eye discomfort in adults over 30, showing clear benefits over a placebo in two l…
Meta-analysis finds fluoroquinolone prophylaxis reduces febrile neutropenia in pediatric ALL
Oncology Meta-analysis
Meta-analysis finds fluoroquinolone prophylaxis reduces febrile neutropenia in pediatric ALL Fluoroquinolone antibiotics lower febrile neutropenia risk in children with acute lymphoblastic leukemia during treatment start
This systematic review and meta-analysis of 991 children with acute lymphoblastic leukemia found that fluoroquinolone prophylaxis reduced fe…
A review of children with acute lymphoblastic leukemia shows fluoroquinolone antibiotics reduce febrile neutropenia risk. This finding sugge…
Nicotinamide riboside and NAD+ injections show preliminary safety in healthy participants
Drug Pipeline RCT
Nicotinamide riboside and NAD+ injections show preliminary safety in healthy participants Nicotinamide Riboside Injections Are Safe But Cause Mild Pain
This Phase 1 RCT in healthy participants assessed bolus injections of nicotinamide riboside or NAD+. The study found 100% participant retent…
New injection data shows Nicotinamide Riboside is safe but causes mild pain and soreness for most people.
Systematic review of 17 studies shows advanced Monte Carlo strategies outperform or match conventional algorithms in clinical linear accelerators
Oncology Meta-analysis
Systematic review of 17 studies shows advanced Monte Carlo strategies outperform or match conventional algorithms in clinical linear accelerators Radiation therapy just got far more precise
This systematic review synthesizes evidence from 17 eligible studies across Varian-, Elekta-, and Siemens-associated platforms evaluating ad…
Radiation therapy is becoming far more precise, thanks to faster simulations that model how energy travels through the body with unmatched a…
Genomically tailored multiagent regimen shows limited efficacy in recurrent glioblastoma
Genetics & Precision Medicine Phase I
Genomically tailored multiagent regimen shows limited efficacy in recurrent glioblastoma Personalized drug combos extend life in brain cancer
This phase I trial tested a genomically tailored multiagent regimen in 30 adults with recurrent glioblastoma. Median overall survival was 12…
A new approach using tailored drug combinations is helping some patients with recurring brain cancer live longer, offering fresh hope where …
Tirzepatide improves standard and intensive therapeutic target attainment versus semaglutide in adults with type 2 diabetes
Drug Pipeline RCT
Tirzepatide improves standard and intensive therapeutic target attainment versus semaglutide in adults with type 2 diabetes New drug helps more patients hit four key health goals at once
This post hoc analysis of a randomised phase 3 study included 1879 adults with type 2 diabetes followed for 40 weeks.
A new diabetes medicine helps more people hit their blood sugar, weight, and blood pressure goals at the same time
Sepiapterin reduces blood phenylalanine more than sapropterin in PKU patients
Drug Pipeline RCT
Sepiapterin reduces blood phenylalanine more than sapropterin in PKU patients Sepiapterin beats sapropterin for lowering blood levels
This Phase 3, randomized, crossover trial in 82 children and adults with phenylketonuria compared sepiapterin to sapropterin.
New research shows a specific vitamin treatment works much better than current options for a rare genetic condition.
Plozasiran reduces recurrent pancreatitis in familial chylomicronaemia syndrome post hoc analysis
Drug Pipeline RCT
Plozasiran reduces recurrent pancreatitis in familial chylomicronaemia syndrome post hoc analysis New drug slashes pancreatitis attacks in high-risk patients
This post hoc analysis of a Phase 3 RCT in 67 adults with very severe hypertriglyceridemia and pancreatitis history found that subcutaneous …
A new treatment cuts pancreatitis flare-ups in people with dangerously high blood fats, offering hope for those with few options and constan…
Romosozumab improves shear bone strength in postmenopausal women with osteoporosis in BCT substudies
Drug Pipeline RCT
Romosozumab improves shear bone strength in postmenopausal women with osteoporosis in BCT substudies Romosozumab May Help Spinal Fusion Surgery Last Longer
This retrospective secondary analysis of phase 2 and 3 randomized trial data evaluated romosozumab in postmenopausal women with low bone den…
A bone drug may make spinal fusion surgery more secure for women with weak bones, new virtual tests suggest.
Narrative review discusses Ganoderma lucidum polysaccharides for diabetes and related complications
Drug Pipeline Sys. Review
Narrative review discusses Ganoderma lucidum polysaccharides for diabetes and related complications New research shows mushroom compounds may help control blood sugar and fix organ damage
This narrative review examines the theoretical potential of Ganoderma lucidum polysaccharides (GLPs) for diabetes and associated conditions.
A common mushroom extract could help lower blood sugar and heal organ damage for millions of people with diabetes
Narrative review on multi-omic technologies for pediatric sepsis biomarker discovery
Drug Pipeline Sys. Review
Narrative review on multi-omic technologies for pediatric sepsis biomarker discovery Multi-omic technologies may transform pediatric sepsis care from empiric treatment to precision medicine
This narrative review synthesizes evidence on multi-omic technologies and computational biology for pediatric sepsis biomarker discovery.
A review suggests multi-omic technologies could shift pediatric sepsis care from empiric treatment to precision medicine.
Systematic review and meta-analysis of Yupingfeng Powder for bronchial asthma in adults
Drug Pipeline Meta-analysis
Systematic review and meta-analysis of Yupingfeng Powder for bronchial asthma in adults A Chinese Herbal Formula Boosts Asthma Control When Paired With Standard Care
This systematic review and meta-analysis synthesized evidence on Yupingfeng Powder combined with conventional therapy for adult bronchial as…
Adults with asthma saw better symptom control and lung function when Yupingfeng powder was added to standard therapy, with few side effects.
Narrative review of Shenfu Injection for sepsis-induced gastrointestinal injury and septic shock
Drug Pipeline Meta-analysis
Narrative review of Shenfu Injection for sepsis-induced gastrointestinal injury and septic shock A Chinese herbal therapy may protect the gut during septic shock
This narrative review examines Shenfu Injection for sepsis-induced acute gastrointestinal injury and septic shock.
A traditional Chinese herbal blend may help protect the gut during septic shock, offering a new angle on a deadly complication that often go…
Meta-analysis of Chinese decoctions for migraine shows varied efficacy rankings across three botanical interventions.
Drug Pipeline Meta-analysis
Meta-analysis of Chinese decoctions for migraine shows varied efficacy rankings across three botanical interventions. New analysis ranks best herbal treatments for migraine pain
This Bayesian network meta-analysis synthesizes data from 57 randomized controlled trials involving 6,005 patients with migraine.
A new analysis of dozens of Chinese herbal formulas reveals which ones may ease migraine pain, frequency, and duration better than others, o…
Case report and literature review of thymoma associated with stiff person syndrome and myasthenia gravis
Oncology Sys. Review
Case report and literature review of thymoma associated with stiff person syndrome and myasthenia gravis A Rare Muscle Stiffness Link to Thymoma Tumor Explained
This case report and literature review examines the association between thymoma and autoimmune syndromes including stiff person syndrome and…
A rare mix of muscle stiffness and weakness was traced to a thymoma tumor, with new genetic clues pointing to a shared immune cause.
Meta-analysis of artificial intelligence models for predicting prostate cancer outcomes
Oncology Meta-analysis
Meta-analysis of artificial intelligence models for predicting prostate cancer outcomes AI Predicts Prostate Cancer Outcomes With 80 Percent Accuracy
This meta-analysis evaluated 85 studies regarding the performance of artificial intelligence models in predicting various prostate cancer ou…
New AI tools can predict prostate cancer outcomes with over 80 percent accuracy, helping men and their doctors make better treatment decisio…
Case report on laparoscopic excision of retroperitoneal mixed type unicentric Castleman disease
Oncology Sys. Review
Case report on laparoscopic excision of retroperitoneal mixed type unicentric Castleman disease Rare Mass Behind Organs Causes Frequent Urination Symptoms
This is a case report of a 52-year-old female with retroperitoneal mixed type unicentric Castleman disease.
Frequent urination led doctors to find a rare tumor behind the organs that surgery removed successfully with full recovery.
Cryoablation may offer greater tumor reduction and fewer adverse events than HIFU for breast fibroadenoma
Oncology Meta-analysis
Cryoablation may offer greater tumor reduction and fewer adverse events than HIFU for breast fibroadenoma Two painless options shrink breast lumps with different tradeoffs
A meta-analysis of prospective single-arm studies compared high-intensity focused ultrasound (HIFU) and cryoablation for breast fibroadenoma…
Freezing breast lumps removes more tissue than heat but causes slightly more skin irritation in these new findings
Frailty is associated with increased prevalence of depressive symptoms in adults with cancer
Oncology Meta-analysis
Frailty is associated with increased prevalence of depressive symptoms in adults with cancer Frailty strongly linked to depression in cancer patients
A meta-analysis of cross-sectional studies examined the relationship between frailty and depression in adults with cancer.
Frail cancer patients are nearly six times more likely to struggle with depression, a major red flag for care teams and families.
CDK4/6 inhibitors plus endocrine therapy improve survival in advanced hormone receptor-positive breast cancer
Oncology Meta-analysis
CDK4/6 inhibitors plus endocrine therapy improve survival in advanced hormone receptor-positive breast cancer CDK4/6 Inhibitors Boost Survival In Advanced Breast Cancer
This meta-analysis of 11 phase 3 trials involving 6035 patients demonstrates that CDK4/6 inhibitors combined with endocrine therapy signific…
New data shows adding CDK4/6 inhibitors to hormone therapy helps patients live longer with advanced breast cancer.
1-Hz TMS targeting right dlPFC reduced amygdala reactivity and PTSD symptoms in 50 adults with PTSD symptoms compared with sham
Genetics & Precision Medicine RCT
1-Hz TMS targeting right dlPFC reduced amygdala reactivity and PTSD symptoms in 50 adults with PTSD symptoms compared with sham Personalized Brain Stimulation Shows Promise For Long Term PTSD Relief
This randomized clinical trial enrolled 50 adults with PTSD symptoms.
Brain scans guide magnetic pulses to reduce fear responses in PTSD patients over several months of recovery time.
Review of X chromosome inactivation in women with pathogenic variants and cancer risk
Genetics & Precision Medicine Sys. Review
Review of X chromosome inactivation in women with pathogenic variants and cancer risk Women with X-linked cancer risks face unique genetic challenges
This narrative review examines X chromosome inactivation and its implications for women carrying pathogenic variants on the X chromosome.
A review explores how X chromosome inactivation affects women carrying pathogenic variants linked to cancer and X-linked syndromes.
S-1 plus oxaliplatin consolidation shows low toxicity in stage II/III lower rectal cancer patients
Oncology Phase I
S-1 plus oxaliplatin consolidation shows low toxicity in stage II/III lower rectal cancer patients First study reports SOX consolidation for lower rectal cancer
This Phase I study enrolled 12 patients with stage II/III lower rectal adenocarcinoma.
A small early trial found SOX chemotherapy was safe after radiation for lower rectal cancer, with surgery completed on time for all patients…
Phase II trial of oral pamiparib in recurrent ovarian cancer after prior PARPi exposure
Oncology Phase II
Phase II trial of oral pamiparib in recurrent ovarian cancer after prior PARPi exposure Pamiparib alone offers limited hope for ovarian cancer patients who have already tried other drugs
This prospective Phase II clinical trial enrolled 15 patients with recurrent ovarian cancer after prior PARPi exposure.
New data shows taking pamiparib by itself works for only a small number of women with recurrent ovarian cancer after other treatments failed
Lyophilized pegaspargase shows similar activity to liquid form in pediatric ALL
Oncology RCT
Lyophilized pegaspargase shows similar activity to liquid form in pediatric ALL Lyophilized pegaspargase shows similar activity and safety to liquid form for pediatric leukemia patients
This phase 2 study in 89 pediatric ALL patients in Russia found that lyophilized pegaspargase had similar maximum plasma asparaginase activi…
A new form of pegaspargase works just like the liquid version for treating acute lymphoblastic leukemia in children in Russia.
Pilot study explores ketogenic diet effects on symptoms in adults with generalized myasthenia gravis
Oncology RCT
Pilot study explores ketogenic diet effects on symptoms in adults with generalized myasthenia gravis Ketogenic diet may improve daily function in myasthenia gravis
This randomized, controlled, open-label pilot study examined whether a ketogenic diet improves functional status and quality of life in adul…
A small pilot trial hints that a keto diet could ease daily struggles for people with myasthenia gravis, but larger studies are needed.
Mecapegfilgrastim reduces grade 3+ neutropenia in treatment-naive diffuse large B-cell lymphoma patients versus no prophylaxis
Oncology RCT
Mecapegfilgrastim reduces grade 3+ neutropenia in treatment-naive diffuse large B-cell lymphoma patients versus no prophylaxis New Drug Cuts Severe Infection Risk In Lymphoma Care
This randomized controlled trial evaluated mecapegfilgrastim in 42 treatment-naive patients with diffuse large B-cell lymphoma.
A new long-acting injection lowers the risk of dangerous low white blood cell counts in lymphoma patients starting their first round of chem…
Post-hoc analysis suggests regional hyperthermia plus chemotherapy may improve survival in extremity soft tissue sarcoma
Oncology RCT
Post-hoc analysis suggests regional hyperthermia plus chemotherapy may improve survival in extremity soft tissue sarcoma Adding heat to chemo may improve survival for soft-tissue sarcoma patients
This post-hoc analysis of a randomized trial examined overall survival in patients with extremity soft tissue sarcoma receiving neoadjuvant …
A post-hoc analysis of a randomized trial suggests adding regional hyperthermia to chemotherapy improved survival for patients with extremit…
Interferon-alpha gel reduces recurrence in nasal inverted papilloma patients compared to surgery alone
Oncology RCT
Interferon-alpha gel reduces recurrence in nasal inverted papilloma patients compared to surgery alone Interferon gel shows no benefit for nasal tumor recovery after surgery
This randomized controlled trial enrolled 42 newly diagnosed nasal inverted papilloma patients.
A small trial found that adding interferon gel to surgery did not improve recovery scores for patients with nasal inverted papilloma compare…
Adding adrenaline to bupivacaine for lipoma plane block reduces blood loss and pain
Oncology RCT
Adding adrenaline to bupivacaine for lipoma plane block reduces blood loss and pain Adrenaline in local blocks reduces pain and bleeding during lipoma surgery
This prospective randomized trial in 40 adults undergoing lipoma excision found that adding adrenaline (1:200,000) to bupivacaine for ultras…
Adding adrenaline to a local anesthetic block lessened pain and bleeding for patients having lipoma removal, based on a trial of 40 adults.
Digital collaboration with patient representatives reduces travel costs and effort in psycho-oncology research
Oncology RCT
Digital collaboration with patient representatives reduces travel costs and effort in psycho-oncology research Digital collaboration reduces costs and barriers for cancer patients
This qualitative study involved 5 patient representatives from the Reduct trial.
A small qualitative study suggests digital tools may lower travel costs and improve flexibility for cancer patients, though technical and co…
Qualitative review finds governance gaps limit feasibility of lifelong genomic medicine in US health systems
Genetics & Precision Medicine
Qualitative review finds governance gaps limit feasibility of lifelong genomic medicine in US health systems Lifelong genomic medicine faces governance gaps, experts say
This qualitative review synthesizes perspectives from over 50 US-based healthcare professionals regarding lifelong genomic medicine.
Healthcare experts endorse lifelong genomic medicine but say governance gaps in consent, data stewardship, and recontact limit its feasibili…
Personalized medication regimens improved blood pressure control in 776 hypertensive outpatients over eight weeks
Genetics & Precision Medicine RCT
Personalized medication regimens improved blood pressure control in 776 hypertensive outpatients over eight weeks Personalized drug plans may lower uncontrolled blood pressure risk in hypertension patients
This multicenter, single-blind, prospective, randomized controlled trial enrolled 776 hypertensive outpatients across eight hospitals.
A trial of 776 patients found personalized medication plans based on genetics improved blood pressure control and reduced drug use.
Meta-analysis finds frozen section reliable for tumor-free margins in OSCC
Oncology Meta-analysis
Meta-analysis finds frozen section reliable for tumor-free margins in OSCC Surgeons rely on frozen sections to ensure clean cuts for oral cancer patients
This systematic review and meta-analysis of 19 studies (9 with complete data) assessed frozen section analysis for detecting tumor-free marg…
A new review confirms that frozen section analysis is a highly reliable way for surgeons to check if oral cancer has been fully removed duri…
Meta-analysis: Temporary uterine artery ligation reduces blood loss in myomectomy
Oncology Meta-analysis
Meta-analysis: Temporary uterine artery ligation reduces blood loss in myomectomy Temporary uterine artery ligation reduces blood loss during fibroid surgery
This systematic review and meta-analysis of 857 women found that adding temporary uterine artery ligation (TUAL) to laparoscopic myomectomy …
A meta-analysis of 857 women found that adding temporary uterine artery ligation to fibroid surgery reduced blood loss and hemoglobin drop.
Systematic review and meta-analysis identifies factors influencing quality of life in colorectal cancer survivors
Oncology Meta-analysis
Systematic review and meta-analysis identifies factors influencing quality of life in colorectal cancer survivors Social support and resilience boost quality of life for colorectal cancer survivors
This systematic review and meta-analysis synthesizes evidence on factors affecting quality of life in colorectal cancer survivors.
A meta-analysis found that social support, resilience, and self-efficacy are linked to better quality of life in colorectal cancer survivors…
High tumour mutation burden improves overall survival in solid tumours treated with immune checkpoint inhibitors
Oncology Meta-analysis
High tumour mutation burden improves overall survival in solid tumours treated with immune checkpoint inhibitors High Mutation Counts May Predict Better Cancer Survival Outcomes
This systematic review and meta-analysis evaluated 5278 patients with solid tumours treated with immune checkpoint inhibitors or chemotherap…
High mutation counts in tumors may help predict who will survive longer when taking powerful immune-boosting cancer drugs
Meta-analysis of pucotenlimab shows improved outcomes across multiple solid tumors
Oncology Meta-analysis
Meta-analysis of pucotenlimab shows improved outcomes across multiple solid tumors New analysis shows pucotenlimab improves outcomes for several solid tumor types
This meta-analysis evaluated pucotenlimab (HX008) in patients with gastric, gastroesophageal junction, triple-negative breast cancer, melano…
A new analysis of pucotenlimab shows significantly improved outcomes versus control for patients with gastric cancer, triple-negative breast…
Meta-analysis of bevacizumab therapy in recurrent glioblastoma multiforme shows associations with improved outcomes
Oncology Meta-analysis
Meta-analysis of bevacizumab therapy in recurrent glioblastoma multiforme shows associations with improved outcomes Bevacizumab therapy linked to better survival and fewer bleeding risks in recurrent brain cancer
This meta-analysis evaluates bevacizumab (BEV) therapy, temozolomide (TMZ), and lomustine in patients with recurrent glioblastoma multiforme…
A large review of patients with recurrent brain cancer found bevacizumab therapy linked to better survival and fewer bleeding risks compared…
Systematic review and meta-analysis of unmet supportive care needs in 32,493 adults with cancer
Oncology Meta-analysis
Systematic review and meta-analysis of unmet supportive care needs in 32,493 adults with cancer Cancer patients need more help with information and mental health support now
This systematic review and meta-analysis evaluated unmet supportive care needs among 32,493 adults with cancer.
A massive review of over 32,000 patients shows that information and emotional support are the biggest gaps in cancer care today
Review of PBMC processing conditions in head and neck squamous cell carcinoma treatment-naive patients
Oncology
Review of PBMC processing conditions in head and neck squamous cell carcinoma treatment-naive patients New blood test method avoids risky biopsies for cancer patients
This observational study review examines peripheral blood mononuclear cell (PBMC) processing conditions for treatment-naive patients with he…
A new blood processing method lets doctors track immune health without risky biopsies for head and neck cancer patients.
Observational study identifies four immune subtypes in newly-diagnosed glioma grades 2-4 among 354 patients
Oncology
Observational study identifies four immune subtypes in newly-diagnosed glioma grades 2-4 among 354 patients New immune map shows how glioma types affect survival chances
This primary research article describes an observational study of 354 patients with newly-diagnosed glioma grades 2-4.
A new map of immune cells in brain tumors reveals four types that predict survival and guide future treatment choices for patients.
Protocol outlines feasibility study of genomic newborn screening for 100,000 births in England
Genetics & Precision Medicine
Protocol outlines feasibility study of genomic newborn screening for 100,000 births in England Newborn Screening Could Catch Rare Diseases Earlier
This study protocol describes a planned investigation into the feasibility and acceptability of offering genomic newborn screening in routin…
A huge new study will test if DNA screening can safely find rare diseases in newborns before symptoms appear.
Sex differences in genetic correlation between ischaemic heart disease and depression found in 1.14 million European ancestry individuals
Genetics & Precision Medicine Cohort
Sex differences in genetic correlation between ischaemic heart disease and depression found in 1.14 million European ancestry individuals Genetic links between heart disease and depression are twice as strong in women
This review analysis of summary statistics from a sex-stratified genome-wide association study involving 1.14 million European ancestry indi…
Genetic links between heart disease and depression are twice as strong in women. This analysis of 1.14 million people shows why sex matters …
Narrative review explores colorectal cancer mutations and tumor microenvironment interactions for TASIN-1
Drug Pipeline Sys. Review
Narrative review explores colorectal cancer mutations and tumor microenvironment interactions for TASIN-1 TASIN-1 and tumor mutations linked to colorectal cancer responses
This narrative review examines the interconnections among specific mutations, the tumor microenvironment, and treatment responsiveness in co…
A narrative review explores how specific genetic mutations and tumor environment interactions may influence treatment responses in colorecta…
PHS601-based stratification increases prostate cancer risk estimates in Norwegian population-based cohorts
Oncology Cohort
PHS601-based stratification increases prostate cancer risk estimates in Norwegian population-based cohorts Genetic test shows higher prostate cancer risk in specific groups
This cohort study evaluated PHS601-based stratification in Norwegian population-based cohorts.
A genetic test linked to prostate cancer risk found that men in the top 1.8 percent of scores faced nearly nine times higher risk than avera…
Metabolic syndrome increases chronic pancreatitis risk in UK Biobank participants
Drug Pipeline Cohort
Metabolic syndrome increases chronic pancreatitis risk in UK Biobank participants Metabolic syndrome doubles risk of chronic pancreatitis in large UK study
This prospective cohort study analyzed 349,995 UK Biobank participants free of chronic pancreatitis at baseline.
A massive study of nearly 350,000 people found that metabolic syndrome significantly increases the risk of developing chronic pancreatitis o…
Review of Aconitum carmichaelii Debeaux toxicity and processing limitations
Drug Pipeline Cohort
Review of Aconitum carmichaelii Debeaux toxicity and processing limitations Fuzi detoxification methods reduce deadly risks for heart and nerves
This review synthesizes evidence regarding the toxic components and detoxification processing of Aconitum carmichaelii Debeaux.
New review shows how careful processing turns a deadly herb into a safe medicine that protects your heart and nerves
Retrospective cohort study links PPI use to drug-related problems in hospitalized renal disease patients
Drug Pipeline Cohort
Retrospective cohort study links PPI use to drug-related problems in hospitalized renal disease patients Nearly half of hospitalized kidney patients had drug problems linked to stomach acid reducers
This retrospective cohort study evaluated 520 hospitalized internal nephrology inpatients to assess drug-related problems (DRPs) associated …
Nearly half of hospitalized kidney patients faced drug problems linked to stomach acid reducers. Other medicines and dialysis types also rai…
Systematic review and meta-analysis of leukotriene receptor antagonist use and neuropsychiatric risk in adults and children
Drug Pipeline Meta-analysis
Systematic review and meta-analysis of leukotriene receptor antagonist use and neuropsychiatric risk in adults and children Adults on LTRAs show higher neuropsychiatric risk than children in this analysis
This systematic review and meta-analysis evaluated the association between leukotriene receptor antagonist (LTRA) use and neuropsychiatric d…
A meta-analysis of 21 studies found a statistically significant link between leukotriene receptor antagonist use and neuropsychiatric events…